Bayer Cropscience India Limited

Bayer Cropscience India Limited

3,383.50
INR
-66.10
(-1.92%)
162.90EPS
25.45P/E
186.35BMarket Cap
Nov 03Next Earn
Bayer Cropscience India Limited
NSE:BAYERCROP
(National Stock Exchange of India)

Recent

price

3,383.50

P/E

ratio

25.45

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
516.14
558.09
664.83
816.59
987.27
744.25
768.74
749.64
715.08
783.01
921.81
1,018.35
1,100.28
1,088.53
1,182.43
1,223.35
1,245.01
Revenue per Share
33.32
35.19
294.11
75.14
104.59
87.34
82.31
86.16
78.46
105.58
109.72
143.58
168.71
164.77
126.38
153.35
162.9
Basic EPS, GAAP
12.23
27.01
35.01
73.06
54.73
57.24
44.49
34.85
86.72
138.98
143.45
35.62
118.37
201.57
48.64
225.62
- -
Free Cash Flow per Basic Share
4
3.97
4.2
5.11
9.48
17.21
16.94
17.2
29.35
22.58
114.81
149.7
124.85
135
124.78
125.23
- -
Dividend per Share
170.39
200.69
488.95
475.79
576.37
520.28
581.74
517.95
652.25
572.4
567.46
561.68
603.47
634.02
634.24
659.89
- -
Book Value per Share
169.47
199.75
488.22
475.3
576.04
516.69
573.49
506.56
639.84
560.39
551.84
541.81
577.94
606.11
603.89
625.34
- -
Tangible Book Value per Share
39
39
39
39
37
36
35
35
43
45
45
45
45
45
45
45
45
Basic Weighted Avg Shares
20,387
22,044
26,260
31,462
36,153
26,850
27,178
26,111
30,724
35,190
41,428
45,767
49,449
48,921
53,141
54,980
55,954
Sales/Revenue/Turnover
9.96
10.65
12.99
12.17
14.03
16.01
14.82
14.9
15.08
18.99
18
16.61
17.39
18.57
11.47
14.26
13.87
Operating Margin (%)
327
450
462
646
253
247
289
331
438
653
735
645
795
740
849
940
1,169
Depreciation Expense
1,316
1,390
11,617
2,895
3,830
3,151
2,910
3,001
3,371
4,745
4,931
6,453
7,582
7,405
5,680
6,892
7,321
Net Income, GAAP
33.8
32
25.68
34.32
33.22
34.57
35.03
25.68
29.77
18.62
37.94
23.8
23.42
21.34
19.71
19.38
20.58
Effective Tax Rate (%)
6.46
6.31
44.24
9.2
10.59
11.74
10.71
11.49
10.97
13.48
11.9
14.1
15.33
15.14
10.69
12.54
13.08
Profit Margin (%)
5,204
4,861
15,562
12,583
17,753
14,995
16,911
14,142
15,919
18,750
19,733
19,162
21,189
23,081
22,479
23,508
- -
Working Capital
1,085
- -
- -
- -
- -
- -
- -
- -
- -
138
141
518
364
210
616
388
- -
LT Debt
6,730
7,927
19,313
17,423
21,106
18,394
20,567
17,783
22,394
25,725
25,503
25,243
27,121
28,494
28,504
29,657
- -
Total Equity
16.7
14.65
82.73
13.22
17.44
14.2
13.42
15.03
15.89
18.23
17.66
23.25
26.96
24.45
17.38
21.57
- -
Return on Invested Capital (%)
17.53
16.66
85.5
15.93
20.04
16.29
15.17
16.09
17.14
20
19.29
25.26
28.73
26.61
19.88
23.49
- -
Return on Capital (%)
21.35
18.97
85.29
15.76
19.88
15.95
14.94
15.65
16.78
19.72
19.25
25.43
28.96
26.63
19.93
23.7
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
430
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
388
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
45
45
45
Market Capitalization
204,846
208,783
186,352

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
49,183
- -
Cash, Cash Equivalents & STI
- -
14,720
- -
Accounts Receivable, Net
- -
11,155
- -
Inventories
- -
21,355
- -
Total Current Liabilities
- -
25,675
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
430
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.38%
3.11%
4.05%
Free Cash Flow
74.65%
103.08%
363.86%
Net Income, GAAP
9.66%
8.82%
21.34%
Sales/Revenue/Turnover
7.68%
5.91%
3.46%
Total Cash Common Dividend
- -
2.94%
0.36%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
16,312
17,382
10,569
10,464
53,141
2026
19,146
15,534
11,062
11,008
54,980
2027
18,350
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
56.56
30.33
7.61
31.88
126.38
2026
62.01
33.98
21.29
36.07
153.35
2027
71.56
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
124.78
2026
- -
- -
- -
- -
125.23
2027
- -
- -
- -
- -
- -
Business
Bayer CropScience Limited is an Indian agrochemical company primarily engaged in manufacturing and selling crop protection products, seeds, and digital farming solutions. Its core product portfolio includes insecticides, fungicides, herbicides, corn seeds, soybean seeds, vegetable seeds, and genetic traits designed to enhance crop performance such as drought tolerance, pest resistance, herbicide tolerance, and improved nutrition. The company also offers biological solutions like biopesticides derived from natural organisms and bio-stimulants that boost plant growth and stress resilience. Bayer CropScience serves agricultural markets across India and has an expanded footprint including operations in the Americas, Europe, and Asia, targeting commercial growers and farmers in diverse agri-climatic zones. Founded in 1967 and headquartered in Thane, India, Bayer CropScience operates as a subsidiary within the global Bayer Group. In recent developments, Bayer CropScience has strategically acquired a canola treating and packaging facility in Coaldale, Alberta, Canada from HyTech Production, enhancing its control over the entire seed production-to-packaging process to better serve farmers and optimize canola hybrid supply. The acquisition, effective November 2024, complements Bayer’s existing seed production and cleaning operations in Canada. Additionally, the company reports strong sales growth in its corn seed and traits business, with a notable 16.6% increase in quarterly sales, driven by demand for non-glyphosate-based herbicides and improved seed genetics. Bayer continues to address regulatory challenges related to glyphosate-based products like Roundup, with litigation containment efforts expected to progress by the end of 2026. These strategic moves underpin Bayer CropScience’s commitment to innovation in crop protection, seed technology, and sustainable agriculture solutions. Overall, Bayer CropScience Limited offers comprehensive crop protection chemicals; high-quality genetically improved seeds across major crops such as corn, soybean, and vegetables; integrated digital farming technologies for yield optimization; and sustainable biological farming products. Its recent operational expansion through facility acquisition and new product introductions highlights its focus on strengthening global supply chains and advancing next-generation agricultural inputs to meet evolving farmer needs. The company maintains a dominant position in the agri-care segment in India while reinforcing its international presence with strategic partnerships and investments in North America and beyond.